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Abstract 
Background: High mobility group box 1 (HMGB1) is a nuclear protein with extracellular inflammatory cytokine activ‑
ity. It is passively released during cell death and secreted by activated cells of many lineages. HMGB1 contains three 
conserved redox‑sensitive cysteine residues: cysteines in position 23 and 45 (C23 and C45) can form an intramolecular 
disulfide bond, whereas C106 is unpaired and is essential for the interaction with Toll‑Like Receptor (TLR) 4. However, 
a comprehensive characterization of the dynamic redox states of each cysteine residue and of their impacts on innate 
immune responses is lacking.
Methods: Primary human macrophages or murine macrophage‑like RAW 264.7 cells were activated in cell cultures 
by redox‑modified or point‑mutated (C45A) recombinant HMGB1 preparations or by lipopolysaccharide (E. coli.0111: 
B4). Cellular phosphorylated NF‑κB p65 subunit and subsequent TNF‑α release were quantified by commercial 
enzyme‑linked immunosorbent assays.
Results: Cell cultures with primary human macrophages and RAW 264.7 cells demonstrated that fully reduced 
HMGB1 with all three cysteines expressing thiol side chains failed to generate phosphorylated NF‑КB p65 subunit 
or TNF‑α. Mild oxidation forming a C23‑C45 disulfide bond, while leaving C106 with a thiol group, was required for 
HMGB1 to induce phosphorylated NF‑КB p65 subunit and TNF‑α production. The importance of a C23–C45 disulfide 
bond was confirmed by mutation of C45 to C45A HMGB1, which abolished the ability for cytokine induction. Further 
oxidation of the disulfide isoform also inactivated HMGB1.
Conclusions: These results reveal critical post‑translational redox mechanisms that control the proinflammatory 
activity of HMGB1 and its inactivation during inflammation.
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Introduction
This report replaces a study (Yang et  al. 2012) that was 
retracted (Yang et  al. 2020) because mass-spectrome-
try data provided by one of the authors had been fabri-
cated. The present report, where the fabricated data were 
removed, reaffirms the functional information reported 
at the time, and can be correctly cited as the first evi-
dence of redox-sensitive properties of HMGB1 regarding 
the ability of the molecule to promote inflammation.
High mobility group box-1 protein (HMGB1), a 
25 kDa nuclear protein with 99 % identity among mam-
mals (Sessa and Bianchi 2007), has been implicated as a 
mediator of tissue damage and inflammation during ster-
ile injury and infection (Andersson and Rauvala 2011). 
It is released passively during cell injury and is secreted 
actively by macrophages and other cell types activated by 
exposure to products of infection or injury. Extracellular 
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HMGB1 signals via TLR4 to activate macrophages to 
release TNF-α, IL-1, IL-6 and other proinflammatory 
molecules (Yang et  al. 2010). Neutralizing HMGB1 
antibodies reverse inflammation and attenuate disease 
severity in animal models (Andersson and Tracey 2011; 
Schierbeck et al. 2011; Wang et al. 1999).
HMGB1 has three major protein domains consist-
ing of two tandem DNA-binding regions (box A and 
box B), and an acidic carboxyl terminus comprised of a 
string of aspartate and glutamate residues (Bianchi et al. 
1989). Initial studies of the structural basis for the extra-
cellular proinflammatory cytokine activity of HMGB1 
revealed a critical role for residues in the B box domain 
(Li et  al. 2003). The first 20 amino acid residues (posi-
tion 89–108) of the B box domain represent the minimal 
peptide sequence that retains cytokine-inducing activity 
by macrophages (Li et al. 2003). The activity of HMGB1 
to stimulate macrophage cytokine production requires 
HMGB1 binding to TLR4, and both binding and signal-
ing require the cysteine in position 106 (C106) within the 
B box domain (Yang et al. 2010).
The induction of immune responses is critically 
intertwined with a dynamic redox environment, and 
posttranslational redox modifications represent key 
mechanisms to regulate protein functions. Understand-
ing the functional relationship between redox modifica-
tions of key inflammatory extracellular signaling proteins, 
such as HMGB1, is thus of great importance. As a redox-
sensitive protein, HMGB1 contains three cysteine resi-
dues: C23, C45, and C106. Recently, it was suggested that 
oxidation of C106 modulates the activity of HMGB1 and 
prevents its capacity to activate dendritic cells (Kazama 
et al. 2008). While the focus to date on redox remodeling 
has been on C106, there are two additional conserved 
cysteine residues present within HMGB1 (C23 and C45). 
The structure:function relationship between modifica-
tions on these residues to the inflammatory activity of 
HMGB1 is unknown. The formation of an intramolecular 
disulfide bond between C23 and C45 stabilizes the folded 
state of the full-length protein and generates a conforma-
tion change (Sahu et al. 2008) that might impact upon the 
signaling function of HMGB1 as an inflammatory media-
tor (Sahu et al. 2008; Stott et al. 2010). The present study 
was thus performed to study posttranslational redox 
mechanisms controlling the cytokine-inducing activity 
of HMGB1. The results indicate that the inflammatory 
activities of HMGB1 require a fully reduced C106 and a 
formation of a disulfide bond between C23 and C45.
Materials and methods
Materials
Lipopolysaccharide (LPS, E. coli.0111: B4), triton X-114 
and human macrophage-colony stimulating factor 
(M-CSF) were purchased from Sigma (St. Louis, MO, 
USA). Isopropyl-D-thiogalactopyranoside (IPTG) was 
from Pierce (Rockford, IL, USA). DNase I and 2xYT 
medium were obtained from Life Technologies (Grand 
Island, NY, USA). Hydrogen peroxide (3 %) was from 
Fisher Scientific (Waltham, MA, USA). Dithiothrei-
tol (DTT, 100 mmol/L) was obtained from Invitrogen 
(Carlsbad, CA, USA). HMGB1 enzyme-linked immu-
nosorbent assay (ELISA) kit was purchased from Shino-
Test Corporation (Tokyo, Japan).
Generation of recombinant and mutant HMGB1 proteins
Wild-type rat HMGB1 was cloned, expressed and puri-
fied as described previously. To generate C45A mutant 
HMGB1, the cysteine at position 45 in the wild-type 
HMGB1 clone was substituted with alanine using the 
QuikChange, Site-Directed Mutagenesis kit according 
to the manufacturer’s instructions (Stratagene, Skar-
holmen, Sweden). The primers used were, forward: 
5′-GAG TTC TCC AAG AAG GCC TCA GAG AGG 
TGG AAG ACC-3′ and reverse: 5′-GGT CTT CCA 
CCT CTC TGA GGC CTT CTT GGA GAA CTC-3′. 
The PCR product was subcloned into the pCAL-n vec-
tor, 3′ to the T7 promotor and CBP tag, expressed and 
purified as described previously (Yang et  al. 2010). 
DNase I was added at 100 U/mL to the beads to remove 
any contaminating DNA. Degradation of DNA was 
verified by ethidium bromide staining of agarose gel 
containing HMGB1 proteins before and after DNase I 
treatment. The purity and integrity of purified HMGB1 
proteins was verified by Coomassie Blue staining after 
SDS-PAGE, with purity predominantly above 90 %. 
Contaminating LPS from protein preparations was 
removed by Triton X-114 extraction as described previ-
ously (Li et al. 2004). LPS content in the protein prepa-
rations was typically less than 0.1 EU/µg protein by the 
LAL method.
Preparation of redox‑modified HMGB1 
or mercury‑exposed HMGB1
HMGB1 was exposed to either hydrogen peroxide  (H2O2; 
0–50 µmol/L) or dithiothreitol (DTT) (0–5 mmol/L) for 
up to 2 h prior to the addition of the protein to cell cul-
ture or other analysis. For rHMGB1 that had been pro-
duced in the presence of DTT, an exposure of 50 µmol/L 
 H2O2 for 2  h was utilized. In order to expose HMGB1 
to mercury, the HMGB1 solution was treated with 1:1 
or 1:10 molar equivalents of 4-(hydroxyl-mercury) ben-
zoic sodium salt. The reaction was stirred at room tem-
perature for 2  h and excess mercury was subsequently 
removed by dialysis against PBS at 4 °C overnight.
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Cell cultures
Peripheral blood mononuclear cells were isolated from 
blood of healthy volunteers (Long Island Blood Ser-
vices, Melville, NY, USA) and differentiated into mac-
rophages using M-CSF. Murine macrophage-like RAW 
264.7 cells were obtained from American Type Culture 
Collection (Rockville, MD, USA). Cells were cultured in 
96 or 6 well plates as described previously (2).
Cytokine measurements
TNF-α released in the supernatants of macrophage 
cultures were measured by commercially available 
enzyme-linked immunosorbent assay (ELISA) kits 
according to instructions of the manufacturer (R&D 
Systems Inc., Minneapolis, MN, USA).
Measurements of cellular phosphorylated NF‑κB p65 
subunit expression
Phosphorylated NF-κB p65 measurement in primary 
human macrophages was performed using RayBio 
NF-kB p65 ELISA kit (Cat #PEL-NFKBP65-S536-T) 
according to the instructions (RayBiotech, Norcross, 
GA). Total cell lysate was prepared and used in the 
assay as per manufacturer’s instructions.
Statistical analysis
Data are presented as mean ± SEM. Differences 
between treatment groups were determined by Student 
t test; one-way ANOVA followed by Tukey’s multiple 
comparison tests or Two-way ANOVA followed by 
Sidak’s multiple comparisons test between groups. P 
values less than 0.05 were considered statistically sig-
nificant by using the Graphpad Prism software.
Results
HMGB1‑induced TNF‑α production requires a disulfide 
bond between C23 and C45 and C106 expressing a thiol 
side chain
The three cysteines present in HMGB1 are strictly 
conserved in all mammals (Sessa and Bianchi 2007). 
Previous studies established that C106 is required for 
HMGB1-induced cytokine release, since a point muta-
tion of C106 prevented the binding to TLR4/MD2 
and subsequent cytokine release from activated mac-
rophages/monocytes (Yang et  al. 2010). Other stud-
ies indicated that an intramolecular disulfide bond 
between C23 and C45 generates a conformation change 
in the full-length protein (Sahu et  al. 2008) and that 
HMGB1 oxidation may impact its inflammatory prop-
erties (Kazama et  al. 2008). However, the structure-
function relationship of the three cysteine residues and 
the cytokine-inducing activity of HMGB1 remains to be 
clarified.
We started the investigation of cysteine redox require-
ments by studying the influence of reducing conditions 
on the cytokine-inducing performance of HMGB1. 
The reducing agent dithiothreitol (DTT) prevents and 
reverses intra- and intermolecular disulfide bond forma-
tion between cysteine residues. RAW 264.7 cells were 
co-cultured with DTT-exposed or non-exposed HMGB1 
and the subsequent TNF-α release was dose-dependently 
reduced by DTT (Fig. 1a). Addition of DTT did not sig-
nificantly alter LPS-induced TNF-α release in the cul-
tures supporting that the effects by DTT on HMGB1 
were specific (Fig. 1b). Time course studies revealed that 
incubation of HMGB1 with DTT for only 5  min sup-
pressed HMGB1 activity as a TNF-α stimulator by up to 
70 % (Fig.  1c). We thus concluded that DTT prevented 
the formation of a disulfide bridge between C23 and C45 
that in turn inhibited TNF-α release.
We further investigated the redox state of the cytokine-
inducing HMGB1 by exposing highly purified recom-
binant HMGB1 to mercury (Hg) to elucidate whether 
C106 expressed a thiol side chain or not when HMGB1 
activated RAW 264.7 cells to release TNF-α. Mercury 
selectively reacts with the thiol side chain of a cysteine, 
but not with other cysteine redox forms. Mercury expo-
sure significantly reduced TNF-α release in Hg-HMGB1 
stimulated cultures as compared to non-Hg exposed cul-
tures (Fig. 1d). These results thus demonstrated that the 
critical C106 residue must be in its fully reduced form 
expressing a thiol side chain to activate TNF-α release. 
Taken together these findings indicated that reduced 
C106 alone was insufficient for HMGB1-mediated TNF-α 
induction and demonstrated that the redox states of all 
three cysteines contributed to the TNF-α-stimulating 
activity of HMGB1. The results implied that the cytokine-
inducing redox form of HMGB1 has a need of a disulfide 
bond between C23 and C45 alongside with C106 express-
ing a thiol side chain (C23-S-S-C45, C106-SH) (Fig. 1d).
Effects of cysteine oxidation on the cytokine‑stimulating 
ability of HMGB1
To further examine the redox state of the cytokine-
inducing isoform of HMGB1 we exposed the molecule 
to various intensities of oxidation. As expected, no 
TNF-α release occurred in RAW 264.7 cell cultures 
stimulated by fully reduced HMGB1 (C23-SH, C45-SH, 
C106-SH) prepared in the presence of DTT (Fig.  2a). 
However, a strong TNF-α release was observed in cul-
tures stimulated by the DTT-prepared HMGB1 that 
had been exposed to mild oxidation caused by hydro-
gen peroxide  (H2O2 50 µM, 120 min) (Fig. 2a). A mild 
oxidation should support a formation of the C23-C45 
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disulfide bond. The restored ability of the DTT-pro-
duced HMGB1 to activate cytokine production after 
mild oxidation is in line with the notion that the 
cytokine-inducing redox isoform of HMGB1 expresses 
a disulfide bridge between C23 and C45 with C106 in 
the thiol form.
The importance of a C23–C45 disulfide bond for 
HMGB1-mediated cytokine production was confirmed 
by mutation of C45 to an alanine in the full length 
HMGB1 protein. This point mutation prevents the 
formation of a disulfide bond between C23 and C45. 
We observed that the C45A HMGB1 mutant had sig-
nificantly reduced TNF-α-stimulating activity in RAW 
264.7 cells compared to the C45-expressing HMGB1 
protein (Fig. 2B).
We then exposed cytokine-inducing HMGB1 to 
robust oxidation by hydrogen peroxide (50mM). The 
strongly oxidized HMGB1 lost its capacity to induce 
TNF-α in cell cultures with RAW 264.7 cells (Fig.  3a) 
as well as with human primary macrophages (Fig. 3b). 
Hydrogen peroxide-exposure of LPS failed to inhibit 
TNF-α-inducing activity, indicating that the effect of 
hydrogen peroxide was HMGB1 specific (Fig.  3c). In 
summary, these results reinforce the identification of 
disulfide HMGB1 as the cytokine-inducing isoform.
Fig. 1 The cytokine‑stimulating activity of HMGB1 requires the presence of a disulfide bond between C23‑C45 and the C106 residue in its fully 
reduced form. a Dose‑dependent effect of DTT on the TNF‑α‑stimulating activity of HMGB1 (1 µg/ml, 16 h incubation), indicating that DTT 
prevented the formation of a disulfide bridge between C23 and C45. *P < 0.05 versus HMGB1 alone without DTT. N = 3. One‑way ANOVA followed 
by Tukey’s multiple comparisons tests. b Lack of DTT‑mediated effect on LPS regarding its TNF‑α‑stimulating activity. c Time‑dependent effect of 
DTT on the TNF‑α‑stimulating activity of HMGB1. One‑way ANOVA followed by Tukey’s multiple comparisons test between groups. *p < 0.05 versus 
HMGB1 without DTT. d The effect of mercury (Hg) on TNF‑α release induced by recombinant HMGB1 prepared in the absence of DTT. Mercury 
selectively binds to thiol side chains. The results implicate that out of the 3 cysteines expressed in HMGB1 it must be C106 carrying a thiol side chain 
in TNF‑α‑inducing HMGB1, since C23 and C45 are engaged in a disulfide bond. n = 3. Two‑way ANOVA followed by Sidak’s multiple comparisons 
test between groups. *p < 0.05 versus Hg‑HMGB1
Fig. 2 Effect of oxidation on HMGB1‑induced TNF‑α release in RAW 
264.7 cells. a Effects of mild  H2O2 exposure (50 µmol/L, 120 min) 
on the TNF‑α stimulating activity of HMGB1 prepared with DTT 
(all‑thiol HMGB1). b Effects of an A45 mutation of HMGB1 on TNF‑α 
release compared with HMGB1 prepared in the absence of DTT 
(disulfide HMGB1). RAW 264.7 cells were incubated with various 
HMGB1 proteins over a range of concentrations (0 to 10 µg/mL) for 
16 h. TNF‑α released into the cell culture supernatant was measured 
by ELISA. N = 3. Two‑way ANOVA followed by Sidak’s multiple 
comparisons test between groups. *p < 0.05 versus all‑thiol or 
C45A‑HMGB1
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Disulfide HMGB1 induces NF‑kB p65 subunit formation
We further studied redox-dependent effects on HMGB1-
induced NF-kB p65 subunit activation in primary 
human macrophages, a process required to initiate the 
production of many proinflammatory cytokines. The 
cytokine-inducing disulfide HMGB1 isoform promoted 
a phosphorylation of NF-kB p65, while DTT-exposed 
HMGB1 and strongly oxidized HMGB1 did not (Fig. 4). 
These results were thus in line with the observed require-
ments for HMGB1-induced TNF-α release being depend-
ent on disulfide HMGB1.
Discussion
Oxidative modification represents a key post-transla-
tional alteration to regulate the functional capacity of 
signaling proteins. Much is known about the functional 
modulation of intracellular proteins such as enzymes 
(phosphatases and kinases) and transcriptional regula-
tors through the chemo-selective oxidation of cysteine 
residues (Spickett and Pitt 2012). Cysteine redox per-
turbation is also thought to alter the extracellular func-
tionality of intercellular signaling proteins (Rubartelli 
and Lotze 2007). During tissue inflammation and repair, 
the changing redox environment following cell death can 
have important consequences on the bioactivity of key 
inflammatory signaling proteins (Vezzoli et al. 2010).
The aim of the current investigation was to provide 
a chemical definition of the pattern of cysteine redox 
Fig. 3 The time‑dependent inhibitory effect of  H2O2 exposure on the TNF‑α‑stimulating activity of HMGB1 in a RAW 267.7 cells and b primary 
human macrophages. c The effect of  H2O2 exposure on the TNF‑α‑stimulating activity of LPS in RAW 264.7 cells. Cells were cultured in 96‑well plates 
and stimulated with HMGB1 or LPS with or without exposure to 50 mM  H2O2 for 0–120 min. Number of experiments in each panel: n = 3. One‑way 


















































































Fig. 4 Redox‑dependent effect on HMGB1‑induced NF‑κB activation 
in primary human macrophages. Analysis of phosphorylated NF‑κB 
p65 subunit following the stimulation of cultured macrophages 
in 6‑well plate for 1 h with HMGB1 (5 µg/mL) or LPS (4 ng/mL). 
HMGB1 was exposed to either  H2O2 (50 mM, 120 min) or DTT (5 
mM, 120 min) prior to the assay. LPS was exposed to DTT (5 mM, 
120 min). Expression of phosphorylated NF‑κB p65 and total NF‑κB 
p65 (loading control) was measured by quantitative ELISA. Data are 
presented as ratio of phospho‑NF‑κB vs. total NF‑κB or means ± SEM. 
n = 3. *p < 0.05. One‑way ANOVA followed by Tukey’s multiple 
comparisons test between groups
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modifications regulating the cytokine-inducing capacity 
of HMGB1. We conclude that to induce cytokine release, 
HMGB1 must simultaneously have C106 in its reduced 
thiol form and C23 and C45 engaged in a disulfide 
bridge. Robust oxidation or full reduction to thiol groups 
each inactivates HMGB1. The modifications induced by 
robust oxidation have not been studied by us and remain 
an important issue to elucidate in future studies.
The most common covalent linkages between protein 
side chains are disulfide bonds, and disulfide-thiol inter-
conversions alter protein properties through changes 
in chemical reactivity and conformation. These redox-
dependent changes will thereby regulate many critical 
functions of signaling proteins including HMGB1 (Hogg 
2003; Park and Lippard 2011). C23 and C45 readily form 
a disulfide bond (Hoppe et al. 2006) which increases the 
stability of the folded full length HMGB1 molecule; NMR 
analysis confirms that this linkage alters the conforma-
tion of the A domain within the HMGB1 protein (Park 
and Lippard 2011; Sahu et al. 2008). C23 and C45 muta-
tions prevent HMGB1 from binding to the intracellular 
target protein Beclin 1, inhibiting HMGB1 from initiating 
cellular autophagy processes (Tang et al. 2010). Mild oxi-
dation of completely reduced HMGB1, which is unable to 
induce cytokine formation, partially restored the C23–
C45 disulfide bond and the cytokine-inducing capacity. 
These findings provide a proof of concept for the criti-
cal role of the C23-S-S-C45 linkage. Surface plasmon 
resonance-based studies, reported several years after our 
observations outlined here by us, confirm that the box 
A and box B domains of HMGB1 both are both needed 
for proper interaction with the TLR4/MD-2 receptor, 
although with different binding and kinetic parameters. 
The box A domain binds to TLR 4 with high affinity and 
slow off-rate, while once in close proximity the box B 
domain binds to MD-2 with low affinity but extremely 
slow off-rate (He et al. 2018). Furthermore, recent stud-
ies in tissue samples obtained from pathological and 
physiological conditions underline a close association of 
disulfide HMGB1 expression with an inflammatory state 
characterized by the presence of immune cells and iden-
tifies leukocytes as reservoirs of disulfide HMGB1 (Fer-
rara et al. 2020; Kwak et al. 2020).
The unpaired cysteine C106 may theoretically form a 
disulfide bridge with another C106 residue on a second 
HMGB1 molecule which might have functional con-
sequences. Dimeric HMGB1 is an alternative chemical 
entity which has not been investigated by us and remains 
a subject for future studies.
Acetylation of key lysine residues within the nuclear 
localization sequence of HMGB1 is thought to act as a 
key regulatory mechanism to promote a nuclear export 
enabling further extracellular release of HMGB1 from 
macrophages and monocytes, and extracellular acety-
lated HMGB1 has been confirmed in vivo (Bonaldi et al. 
2003). Acetylation of nearby lysine residues might change 
the electrostatic potential and affect the  pKa of cysteine 
thiol groups; however, as previously noted (Sahu et  al. 
2008), no lysine amino group is present within 8 Å from 
the thiol groups in the three-dimensional structure of the 
HMGB1, and therefore an impact on the regulation of 
the proinflammatory function of HMGB1 is unlikely.
Since the original description of HMGB1 activity in 
stimulating macrophage cytokine release (Andersson 
et al. 2000), investigations have revealed that HMGB1 can 
act in synergy with other inflammatory mediators to pro-
mote cytokine stimulation (Hreggvidsdottir et  al. 2009). 
Therefore, there has been an ongoing debate concerning 
whether HMGB1 per se, uncomplexed to partner mole-
cules, is capable of inducing cytokine production to pro-
mote inflammation. The results of the current study help 
to resolve this major issue: HMGB1 with reduced C106 
and a disulfide bond between C23 and C45 has cytokine-
stimulating activity, whereas many commercially avail-
able rHMGB1 preparations, being supplemented with 
DTT and fully reduced, are unable to stimulate TNF-α 
production, but highly competent of promoting chemo-
tactic activities (Schiraldi et al. 2012).
Conclusions
In summary, the results provided here reveal a novel 
mechanism to regulate the activities of a key signaling 
protein, HMGB1, and suggest that HMGB1 might be a 
central target of redox modifications during inflamma-
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